| Dr Grant Michael Warmouth, MD | |
|
1511 Onyx Cir, Longmont, CO 80504-7805 | |
| (303) 776-5298 | |
| Not Available |
| Full Name | Dr Grant Michael Warmouth |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 21 Years |
| Location | 1511 Onyx Cir, Longmont, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376757344 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Centura Health-penrose St Francis Health Services | Colorado springs, CO | Hospital |
| Centura Health-avista Adventist Hospital | Louisville, CO | Hospital |
| John C. Lincoln North Mountain Hospital | Phoenix, AZ | Hospital |
| Oklahoma Spine Hospital | Oklahoma city, OK | Hospital |
| Honorhealth Scottsdale Shea Medical Center | Scottsdale, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rocky Mountain Neurodiagnostics Llc | 2860734597 | 7 |
| Rocky Mountain Neurodiagnostics Llc | 2860734597 | 7 |
News Archive
In recent years, advances in CT scanner technology have made perfusion computed tomography (CT) imaging an important diagnostic tool for patients with suspected stroke. Now, researchers at Mayo Clinic are working to reduce radiation dosages used to acquire perfusion and other CT images. Mayo Clinic medical physicist Cynthia McCollough, Ph.D., and her group of researchers presented their findings related to CT dose reduction at the 52nd Annual Meeting of the American Association of Physicists in Medicine on July 20 in Philadelphia.
An antimicrobial agent called Defensin kills tumor cells and shrinks tumor size in fruit flies, with help from a pathway that flags the cells for destruction.
A new journal dedicated to sharing and discussion of informative clinical experiences is coming soon, with the launch of Anesthesia & Analgesia Case Reports, the newest publication of the International Anesthesia Research Society (IARS).
Protherics PLC today announced the initiation of a phase 2a proof-of-concept study of Prolarix, a targeted prodrug chemotherapy being developed for the treaent of primary liver cancer (hepatocellular carcinoma or "HCC"). This follows promising data from a phase 1 study of Prolarix, presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, USA on 2 June 2008.
The draft, which offered insight into the Patient-Centered Outcomes Research Institute's priorities and research agenda, did not single out any specific diseases or treatments. The Institute did seek public comment.
› Verified 1 days ago
| Entity Name | Bruce A Katuna |
|---|---|
| Entity Type | Practitioner - Neurology |
| Entity Identifiers | NPI Number: 1073615704 PECOS PAC ID: 0143127373 Enrollment ID: I20031216000765 |
News Archive
In recent years, advances in CT scanner technology have made perfusion computed tomography (CT) imaging an important diagnostic tool for patients with suspected stroke. Now, researchers at Mayo Clinic are working to reduce radiation dosages used to acquire perfusion and other CT images. Mayo Clinic medical physicist Cynthia McCollough, Ph.D., and her group of researchers presented their findings related to CT dose reduction at the 52nd Annual Meeting of the American Association of Physicists in Medicine on July 20 in Philadelphia.
An antimicrobial agent called Defensin kills tumor cells and shrinks tumor size in fruit flies, with help from a pathway that flags the cells for destruction.
A new journal dedicated to sharing and discussion of informative clinical experiences is coming soon, with the launch of Anesthesia & Analgesia Case Reports, the newest publication of the International Anesthesia Research Society (IARS).
Protherics PLC today announced the initiation of a phase 2a proof-of-concept study of Prolarix, a targeted prodrug chemotherapy being developed for the treaent of primary liver cancer (hepatocellular carcinoma or "HCC"). This follows promising data from a phase 1 study of Prolarix, presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, USA on 2 June 2008.
The draft, which offered insight into the Patient-Centered Outcomes Research Institute's priorities and research agenda, did not single out any specific diseases or treatments. The Institute did seek public comment.
› Verified 1 days ago
| Entity Name | Rocky Mountain Neurodiagnostics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659640381 PECOS PAC ID: 2860734597 Enrollment ID: O20190430000984 |
News Archive
In recent years, advances in CT scanner technology have made perfusion computed tomography (CT) imaging an important diagnostic tool for patients with suspected stroke. Now, researchers at Mayo Clinic are working to reduce radiation dosages used to acquire perfusion and other CT images. Mayo Clinic medical physicist Cynthia McCollough, Ph.D., and her group of researchers presented their findings related to CT dose reduction at the 52nd Annual Meeting of the American Association of Physicists in Medicine on July 20 in Philadelphia.
An antimicrobial agent called Defensin kills tumor cells and shrinks tumor size in fruit flies, with help from a pathway that flags the cells for destruction.
A new journal dedicated to sharing and discussion of informative clinical experiences is coming soon, with the launch of Anesthesia & Analgesia Case Reports, the newest publication of the International Anesthesia Research Society (IARS).
Protherics PLC today announced the initiation of a phase 2a proof-of-concept study of Prolarix, a targeted prodrug chemotherapy being developed for the treaent of primary liver cancer (hepatocellular carcinoma or "HCC"). This follows promising data from a phase 1 study of Prolarix, presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, USA on 2 June 2008.
The draft, which offered insight into the Patient-Centered Outcomes Research Institute's priorities and research agenda, did not single out any specific diseases or treatments. The Institute did seek public comment.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Grant Michael Warmouth, MD 1511 Onyx Cir, Longmont, CO 80504-7805 Ph: (303) 776-5298 | Dr Grant Michael Warmouth, MD 1511 Onyx Cir, Longmont, CO 80504-7805 Ph: (303) 776-5298 |
News Archive
In recent years, advances in CT scanner technology have made perfusion computed tomography (CT) imaging an important diagnostic tool for patients with suspected stroke. Now, researchers at Mayo Clinic are working to reduce radiation dosages used to acquire perfusion and other CT images. Mayo Clinic medical physicist Cynthia McCollough, Ph.D., and her group of researchers presented their findings related to CT dose reduction at the 52nd Annual Meeting of the American Association of Physicists in Medicine on July 20 in Philadelphia.
An antimicrobial agent called Defensin kills tumor cells and shrinks tumor size in fruit flies, with help from a pathway that flags the cells for destruction.
A new journal dedicated to sharing and discussion of informative clinical experiences is coming soon, with the launch of Anesthesia & Analgesia Case Reports, the newest publication of the International Anesthesia Research Society (IARS).
Protherics PLC today announced the initiation of a phase 2a proof-of-concept study of Prolarix, a targeted prodrug chemotherapy being developed for the treaent of primary liver cancer (hepatocellular carcinoma or "HCC"). This follows promising data from a phase 1 study of Prolarix, presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, USA on 2 June 2008.
The draft, which offered insight into the Patient-Centered Outcomes Research Institute's priorities and research agenda, did not single out any specific diseases or treatments. The Institute did seek public comment.
› Verified 1 days ago
William Louis Fink, M.D. Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 1707 Main St, Suite 404, Longmont, CO 80501 Phone: 303-776-9797 Fax: 303-776-7693 | |
Dr. Robert George Ruegg Jr., MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 529 Coffman St, #300, Longmont, CO 80501 Phone: 303-684-0555 Fax: 970-336-5000 | |
Dr. Haven Howell, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 500 Kimbark St, Suite 200, Longmont, CO 80501 Phone: 720-652-0416 Fax: 720-652-0408 | |
Dr. Aaron Gavin Meng, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2345 Bent Way, Longmont, CO 80503 Phone: 303-338-4545 | |
Dr. Alendia Hartshorn, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1511 Onyx Cir, Longmont, CO 80504 Phone: 303-776-5298 | |
Dr. Pierre V Pavot, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2030 Mountain View Ave, Suite 300, Longmont, CO 80501 Phone: 303-485-3535 Fax: 303-485-3536 |